How to Leverage India: Visions of 2020
This article was originally published in Scrip
World leader in biosimilars? Quite possibly. Rigorous enforcer of patent laws? Unlikely. Magnet for pharmaceutical-driven foreign direct investment? Watch this space. As part of Scrip's 'How to Leverage India' Executive Briefing, Anantharaman Kavassery Viswanathan predicts how the Indian pharmaceutical landscape might look in a decade's time. Read the full analysis at scripintelligence.com/india.